Ibuprofen Taper for Pericarditis
For acute pericarditis, ibuprofen should be given at 600 mg every 8 hours for 1-2 weeks (symptom and CRP-guided), then tapered by decreasing the dose by 200-400 mg every 1-2 weeks. 1
Initial Dosing and Duration
The 2015 ESC Guidelines provide the definitive framework for ibuprofen use in pericarditis:
- Starting dose: 600 mg every 8 hours (total 1800 mg/day)
- Treatment duration: 1-2 weeks for uncomplicated acute cases, guided by symptom resolution and CRP normalization
- Always provide gastroprotection (proton pump inhibitor or H2 blocker)
- Always add colchicine on top of ibuprofen (0.5 mg once daily if <70 kg, or 0.5 mg twice daily if ≥70 kg for 3 months) 1
The Taper Protocol
The taper should only begin after:
- Complete resolution of chest pain
- Normalization of C-reactive protein (CRP)
Tapering schedule: Decrease by 200-400 mg every 1-2 weeks 1
Practical example:
- Week 1-2: 600 mg TID (1800 mg/day) - continue until symptoms resolve and CRP normalizes
- Week 3-4: 400 mg TID (1200 mg/day)
- Week 5-6: 400 mg BID (800 mg/day)
- Week 7-8: 400 mg daily (400 mg/day)
- Then discontinue
Recurrent Pericarditis: Modified Approach
For recurrent pericarditis, the approach differs:
- Initial dose range: 600 mg every 8 hours (can range 1200-2400 mg/day total)
- Duration: Weeks to months (significantly longer than acute cases)
- Taper: Same 200-400 mg decrements every 1-2 weeks, but longer tapering times may be needed for resistant cases 1
- Colchicine duration: At least 6 months (not just 3 months) 1
Critical Monitoring Points
CRP is your guide - this cannot be overstated. Each dose reduction should only occur when:
- Patient is completely asymptomatic
- CRP has normalized 1
If symptoms recur during tapering, do not increase the ibuprofen dose. Instead:
- Return to the previous effective dose
- Ensure colchicine is optimized
- Consider adding analgesics for pain control
- Reassess after 1-2 weeks before attempting taper again 1
Common Pitfalls to Avoid
Tapering too quickly: This is a major cause of recurrence. The 1-2 week intervals between dose reductions are minimum timeframes - extend them if needed 1
Starting taper before CRP normalizes: Even if symptoms improve, wait for objective inflammatory marker normalization 1
Forgetting colchicine: Ibuprofen alone has higher recurrence rates. Colchicine reduces recurrence from 37.5% to 16.7% 2
Inadequate initial treatment duration: The most common cause of recurrence is inadequate treatment of the first episode 1
Using corticosteroids prematurely: Steroids increase recurrence risk and should only be used for contraindications to NSAIDs/colchicine or treatment failure 1
Special Populations
Patients with coronary artery disease, heart failure, or renal disease: Consider aspirin instead of ibuprofen (750-1000 mg every 8 hours, tapered by 250-500 mg every 1-2 weeks) 1, 3
Athletes: Restrict physical activity for minimum 3 months after symptom onset, regardless of taper completion 1
Non-athletes: Restrict activity beyond sedentary life until symptoms resolve and CRP normalizes 1
Evidence Quality Note
The ESC Guidelines 1 represent Class I, Level A recommendations for NSAID use with colchicine in pericarditis. Recent data from 2024 4 confirms cardiovascular safety of ibuprofen in this population, with no increased risk of major adverse cardiovascular events. The tapering recommendations, while based on expert consensus (Level C), reflect decades of clinical experience and remain the standard of care.